The Kratom Herald

Mitragyna Speciosa News And Information

Scientific Study Finds That Kratom Has Cytotoxic Effects On Breast Cancer Cells, And Calls For More Research Into Kratom's Anti-Cancer Potential

Kratom short term memory

A previous article on The Kratom Herald discussed how one of Kratom’s alkaloids, Mitraphylline, has anti-cancer properties according to multiple scientific studies. These scientific studies which discovered that Mitraphylline has anti-cancer properties were based on Cat’s Claw though, another plant which contains Mitraphylline, and not based on experiments which involved actual Kratom.

However, apparently there is a scientific study which did find that Kratom itself has anti-cancer potential, and the study is titled ‘Characterization of cytotoxic compounds from the ethrat acetate fraction of Kratom (Mitragyna speciosa Korth) leaves and their activity on T47d breast cancer cells‘.

In this scientific study an experiment was conducted where Kratom was applied to breast cancer cells, and it was found that Kratom literally killed the breast cancer cells, which is called cytotoxicity. Also, it was found that a higher dose of Kratom led to more breast cancer cells dying.

That’s about all the science there is to this particular experiment, and although it is quite simple, the results are promising. The scientists who did this experiment conclude that further research should be done into Kratom’s potential anti-cancer properties.

Indeed, in order to definitively prove that Kratom truly has anti-cancer properties, experiments need to be done on lab rats/mice and then humans, rather than just on cells in a Petri dish like in this experiment. Also, the exact compounds in Kratom which have anti-cancer properties would need to be identified, as well as the exact mechanism for the anti-cancer properties.

On a final note, apparently another scientific study found that Kratom has anti-proliferative effects on Leukemia and Colon Cancer, and this will be covered in the near future on The Kratom Herald.